X-ray computed tomography methods for in vivo evaluation of local drug release systems

Recent advances in drug delivery techniques have necessitated the development of tools for in vivo monitoring of drug distributions. Gamma emission imaging and magnetic resonance imaging suffer from problems of resolution and sensitivity, respectively. We propose that the combination of X-ray CT imaging and image analysis techniques provides an excellent method for the evaluation of the transport of platinum-containing drugs from a localized, controlled release source. We correlated local carboplatin concentration with CT intensity, producing a linear relationship with a sensitivity of 62.6 /spl mu/g/mL per Hounsfield unit. As an example application, we evaluated the differences in drug transport properties between normal and ablated rabbit liver from implanted polymer millirods. The use of three-dimensional visualization provided a method of evaluating the placement of the drug delivery device in relation to the surrounding anatomy, and registration and reformatting allowed the accurate comparison of the sequence of temporal CT volumes acquired over a period of 24 h. Taking averages over radial lines extending away from the center of the implanted millirods and integrating over clinically appropriate regions, yielded information about drug release from the millirod and transport in biological tissues. Comparing implants in normal and ablated tissues, we found that ablation prior to millirod implantation greatly decreased the loss of drug from the immediate area, resulting in a higher average dose to the surrounding tissue. This work shows that X-ray CT imaging is a useful technique for the in vivo evaluation of the pharmacokinetics of platinated agents.

[1]  S. Weinbaum,et al.  Lipid transport aspects of atherogenesis. , 1993, Journal of biomechanical engineering.

[2]  A. Alavi,et al.  Nuclear imaging methods for non-invasive drug monitoring. , 2000, Advanced drug delivery reviews.

[3]  Jin Gao,et al.  Fabrication and characterization of controlled release poly(D,L-lactide-co-glycolide) millirods. , 2001, Journal of biomedical materials research.

[4]  B. Sikic Antineoplastic agents , 2018, Reactions weekly.

[5]  Manbir Singh,et al.  Physics and instrumentation for imaging in-vivo drug distribution. , 2000, Advanced drug delivery reviews.

[6]  A. Evans,et al.  Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. Čemažar,et al.  Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry. , 1997, Journal of Pharmaceutical and Biomedical Analysis.

[8]  J R Griffiths,et al.  Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy. , 2000, Advanced drug delivery reviews.

[9]  W Wolf,et al.  19F-MRS studies of fluorinated drugs in humans. , 2000, Advanced drug delivery reviews.

[10]  N. Hussain Ligand-mediated tissue specific drug delivery. , 2000, Advanced drug delivery reviews.

[11]  Roee S. Lazebnik,et al.  Volume registration using needle paths and point landmarks for evaluation of interventional MRI treatments , 2003, IEEE Transactions on Medical Imaging.

[12]  Willis,et al.  Ligand-targeted liposomes. , 1998, Advanced drug delivery reviews.

[13]  G Gregoriadis,et al.  Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.

[14]  S. Duffull,et al.  Clinical Pharmacokinetics and Dose Optimisation of Carboplatin , 1997, Clinical pharmacokinetics.

[15]  K. Wolf,et al.  Evaluation of efficient chemoembolization mixtures by magnetic resonance imaging therapy monitoring: an experimental study on the VX2 tumor in the rabbit liver. , 1996, Cancer research.